小戝健一郎、西川路侑耶、伊集院広壮、松田恵理子、三井薫
総説『多因子増殖制御型アデノウイルスに夜画期的ながん治療』
Drug Delivery System. doi:10.2745/dds.39.248,2024
Kawakami H, Ijichi N, Obama Y, Matsuda E, Mitsui K,
Nishikawaji Y, Watanabe M, Nagano S, Taniguchi N, Komiya S,
Ken-ichiro Kosai.
An optimal promoter regulating cytokine transgene expression is crucial
for safe and effective oncolytic virus immunotherapy.
Transl Res. S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002. 2024
Junichi Kamizono, Yuya Nishikawaji,Satoshi Nagano,Minako Ikeda,
Yoshiharu Horikawa,Taro Kamisasanuki, Kaoru Mitsui,Eriko Matsuda,
Ken-ichiro Kosai.
Triple-regulated conditionally replicating adenovirus for effective and
safer treatment of peritoneal carcinomatosis.
Biochem Biophys Res Commun. 2024 Dec 10:737:150894.
doi: 10.1016/j.bbrc.2024.150894.Epub 2024 Oct 24.
Subcategories
業績
論文掲載「Translational Research」川上広高、伊地知暢広、小濵祐行、松田恵理子、三井薫、西川路侑耶、渡邉真希、永野聡、谷口昂、小宮節朗、小戝健一郎
『An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy』がTransl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.に掲載されました。
Transl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.
